-
Je něco špatně v tomto záznamu ?
Toward structure-based drug design against the epidermal growth factor receptor (EGFR)
Y. Haddad, M. Remes, V. Adam, Z. Heger
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- erbB receptory antagonisté a inhibitory chemie genetika MeSH
- inhibitory proteinkinas farmakologie MeSH
- lidé MeSH
- ligandy MeSH
- mutace MeSH
- racionální návrh léčiv metody MeSH
- rozhodování MeSH
- simulace molekulového dockingu MeSH
- vazebná místa MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Most of the available crystal structures of epidermal growth factor receptor (EGFR) kinase domain, bound to drug inhibitors, originated from ligand-based drug design studies. Here, we used variations in 110 crystal structures to assemble eight distinct families highlighting the C-helix orientation in the N-lobe of the EGFR kinase domain. The families shared similar mutational profiles and similarity in the ligand R-groups (chemical composition, geometry, and charge) facing the C-helix, mutation sites, and DFG domain. For structure-based drug design, we recommend a systematic decision-making process for choice of template, guided by appropriate pairwise fitting and clustering before the molecular docking step. Alternatively, the binding site shape/volume can be used to filter and select the compound libraries.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004641
- 003
- CZ-PrNML
- 005
- 20220127145108.0
- 007
- ta
- 008
- 220113s2021 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.drudis.2020.10.007 $2 doi
- 035 __
- $a (PubMed)33075469
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Haddad, Yazan $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czech Republic; Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, 612 00 Brno, Czech Republic
- 245 10
- $a Toward structure-based drug design against the epidermal growth factor receptor (EGFR) / $c Y. Haddad, M. Remes, V. Adam, Z. Heger
- 520 9_
- $a Most of the available crystal structures of epidermal growth factor receptor (EGFR) kinase domain, bound to drug inhibitors, originated from ligand-based drug design studies. Here, we used variations in 110 crystal structures to assemble eight distinct families highlighting the C-helix orientation in the N-lobe of the EGFR kinase domain. The families shared similar mutational profiles and similarity in the ligand R-groups (chemical composition, geometry, and charge) facing the C-helix, mutation sites, and DFG domain. For structure-based drug design, we recommend a systematic decision-making process for choice of template, guided by appropriate pairwise fitting and clustering before the molecular docking step. Alternatively, the binding site shape/volume can be used to filter and select the compound libraries.
- 650 _2
- $a vazebná místa $7 D001665
- 650 _2
- $a rozhodování $7 D003657
- 650 _2
- $a racionální návrh léčiv $x metody $7 D015195
- 650 _2
- $a erbB receptory $x antagonisté a inhibitory $x chemie $x genetika $7 D066246
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ligandy $7 D008024
- 650 _2
- $a simulace molekulového dockingu $7 D062105
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a inhibitory proteinkinas $x farmakologie $7 D047428
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Remes, Marek $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czech Republic; Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, 612 00 Brno, Czech Republic
- 700 1_
- $a Adam, Vojtech $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czech Republic; Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, 612 00 Brno, Czech Republic
- 700 1_
- $a Heger, Zbynek $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, CZ-613 00 Brno, Czech Republic; Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, 612 00 Brno, Czech Republic. Electronic address: heger@mendelu.cz
- 773 0_
- $w MED00173737 $t Drug discovery today $x 1878-5832 $g Roč. 26, č. 2 (2021), s. 289-295
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33075469 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127145105 $b ABA008
- 999 __
- $a ok $b bmc $g 1751949 $s 1155790
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 26 $c 2 $d 289-295 $e 20201017 $i 1878-5832 $m Drug discovery today $n Drug Discov Today Dis Mech $x MED00173737
- LZP __
- $a Pubmed-20220113
